Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
The Star Entertainment Group (ASX:SGR) confirms Sydney casino licence suspension extended until September 2025 amid ongoing remediation efforts.
Inca Minerals Limited (ASX:ICG) halts trading pending a proposed capital raising announcement.
Gibb River Diamonds Limited (ASX:GIB) lodges a mining proposal for the Neta Prospect at its Edjudina Gold Project, advancing its operational plans.
SG Fleet Group Limited (ASX:SGF) secures Overseas Investment Office approval for Bidco’s acquisition, pending shareholder and court endorsements.
ClearView Wealth Limited (ASX:CVW) issues A$120 million in subordinated notes to fund operations and support ClearView Life Assurance.
LTR Pharma (ASX:LTP) achieves FDA approval path for SPONTAN and launches Roxus to accelerate US market entry.
Vulcan Energy (ASX:VUL) is recognised as an EU Strategic Project under the Critical Raw Materials Act, advancing sustainable lithium supply in Europe.
EBR Systems (ASX:EBR) reports successful SOLVE-CRT trials and outlines a clear FDA approval pathway for its innovative leadless pacemaker system.
Berkeley Energy Limited (ASX:BKY) addresses increased share price and trading volume, detailing compliance and key developments in Spain’s nuclear sector.